Alport syndrome and thin glomerular basement membrane disease.
Alport syndrome and thin glomerular basement membrane disease.
复制标题
DOI:
10.1681/asn.v991736
复制
发表时间:
1998-09
期刊:
影响因子:
--
通讯作者:
C. Kashtan
中科院分区:
文献类型:
--
作者:
C. Kashtan
Alport syndrome (AS) is a generalized inherited disorder of basement membranes, manifested by hematuria, progressive nephritis with proteinuria and declining renal function, sensorineural deafness, and ocular abnormalities. The natural history of AS is gender-dependent: affected males typically have severe disease, while the course of AS in females tends to be mild. The first description of familial hematuria was provided by Guthrie (1) in 1902. Follow-up studies of this family by Hurst (2) and Alport (3) described the progressive nature of the nephropathy, its association with deafness, and the poorer prognosis in affected males. Electron microscopic investigations carried out by several groups in the early 1970s identified the glomerular basement membrane (GBM) as the site of the primary renal abnormality in AS (4-6). A series of reports between 1980 and 1990 established AS as an inherited disease of type IV collagen: immunohistologic studies revealing abnormal type IV collagen composition of AS basement membranes (7,8); mapping of an Alport locus to the X chromosome (9); cloning of a new type IV collagen gene (COL4A5) and its assignment to the same region of the X chromosome as the Alport locus (10); and, finally, identification of the first COL4AS mutations in patients with X-linked AS ( 1 1).